Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse

Journal of Virology

Volumn 72, Issue 2, 1998, Pages 965-974

  Moffat, Jennifer F ^a   Zerboni, Leigh ^a   Kinchington, Paul R ^b   Grose, Charles ^c   Kaneshima, Hideto ^d   Arvin, Ann M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN C;

ANIMAL EXPERIMENT; ARTICLE; HERPES VIRUS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SCID MOUSE; VARICELLA ZOSTER VIRUS; VIRUS ATTENUATION; VIRUS VIRULENCE;

EID: 0031883831     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.2.965-974.1998     Document Type: Article

References (47)

1. Aldrovandi, G. M., G. Feuer, L. Gao, B. Jamieson, M. Kristeva, I. S. Y. Chen, and J. A. Zack. 1993. The SCID-hu mouse as a model for HIV-1 infection. Nature 363:732-763.
2. Arvin, A. M. 1996. Varicella-zoster virus, p. 2547-2585. In B. N. Fields, D. N. Knipe, and P. M. Howley (ed.), Virology, Lippincott-Raven Publishers, Philadelphia, Pa.
3. Arvin, A. M., C. M. Koropchak, B. R. G. Williams, F. C. Grumet, and S. K. Foung. 1986. Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection. J. Infect. Dis. 154:422-429.
4. Auwaerter, P. G., H. Kaneshima, J. M. McCune, G. Wiegand, and D. E. Griffin. 1996. Measles virus infection of thymic epithelium in the SCID-hu mouse leads to thymocyte apoptosis. J. Virol. 70:3734-3740.
5. Bergen, R. E., P. S. Diaz, and A. M. Arvin. 1990. The immunogenicity of the Oka/Merck varicella vaccine in relation to infectious varicella-zoster virus and relative viral antigen content. J. Infect. Dis. 162:1049-1054.
6. Bogger-Goren, S., K. Baba, P. Hurley, H. Yabuuchi, M. Takahashi, and P. L. Ogra. 1982. Antibody response to varicella-zoster virus after natural or vaccine-induced infection. J. Infect. Dis. 146:260-265.
7. Brunell, P. A., and H. L. Casey. 1964. Crude tissue culture antigen for determination of varicella-zoster complement fixing antibody. Public Health Rep. 79:839-842.
8. Centifanto-Fitzgerald, Y. M., T. Yamaguchi, H. E. Kaufman, M. Tognon, and B. Roizman. 1982. Ocular disease pattern induced by herpes simplex virus is genetically determined by a specific region of viral DNA. J. Exp. Med. 155:475-489.
9. Cheatham, W. J., T. H. Weller, T. F. J. Dolan, and J. C. Dower. 1956. Varicella: report of two fatal cases with necropsy, virus isolation, and serologic studies. Am. J. Pathol. 32:1015-1035.
10. Chomczynski, P., and N. Sacchi. 1987. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
11. Cohen, J. I., and K. E. Seidel. 1994. Absence of varicella-zoster virus (VZV) glycoprotein V does not alter growth of VZV in vitro or sensitivity to heparin. J. Gen. Virol. 75:3087-3093.
12. Croen, K., J. Ostrove, L. Dragovic, and S. Straus. 1988. Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes simplex viruses. Proc. Natl. Acad. Sci. USA 85:9773-9777.
13. Croen, K., and S. Straus. 1991. Varicella-zoster virus latency. Annu. Rev. Microbiol. 4:2391-99.
14. Davison, A. J., and J. E. Scott. 1986. The complete DNA sequence of varicella-zoster virus. J. Gen. Virol. 67:1759-1816.
15. Flynn, S. J., and P. Ryan. 1996. The receptor-binding domain of pseudorabies virus glycoprotein gC is composed of multiple discrete units that are functionally redundant. J. Virol. 70:1355-1364.
16. Friedman, H. M., G. H. Cohen, R. J. Eisenberg, C. A. Seidel, and D. B. Cines. 1984. Glycoprotein C of HSV-1 functions as a C3b receptor on infected endothelial cells. Nature 309:633-635.
17. Gelb, L. D. 1993. Varicella-zoster virus: molecular biology, p. 257-279. In B. Roizman, R. J. Whitley, and C. Lopez (ed.), The human herpes viruses. Raven Press, New York, N.Y.
18. Gershon, A. A., P. LaRussa, I. Hardy, S. Steinberg, and S. Silverstein. 1992. Varicella vaccine: the American experience. J. Infect. Dis. 166(Suppl. 1): S63-S68.
19. Grose, C. 1996. Pathogenesis of infection with varicella vaccine, p. 489-505. In R. W. Ellis and C. J. White (ed.), Infectious disease clinics of North America. W. B. Saunders Co., Philadelphia, Pa.
20. Harson, R., and C. Grose. 1995. Egress of varicella-zoster virus from the melanoma cell: a tropism for the melanocyte. J. Virol. 69:4994-5010.
21. Herold, B. C., D. WuDunn, N. Soltys, and P. G. Spear. 1991. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J. Virol. 65:1090-1098.
22. Huemer, H. P., C. Larcher, and N. E. Coe. 1992. Pseudorabies virus glycoprotein-III derived from virions and infected cells binds to the 3rd component of complement. Virus Res. 23:271-280.
23. Kaneshima, H., C.-C. Shih, R. Namikawa, L. Rabin, G. Outzen, S. G. Machado, and J. M. McCune. 1991. Human immunodeficiency virus infection of human lumph nodes in the SCID-hu mouse. Proc. Natl. Acad. Sci. USA 88:4523-4527.
24. Kinchington, P., and G. Cohen. Personal communication.
25. Kinchington, P. R., P. Ling, M. Pensiero, A. Gershon, J. Hay, and W. T. Ruyechan. 1990. A Possible role for glycoprotein gpV in the pathogenesis of varicella-zoster virus, p. 83-91. In C. Lopez (ed.), Immunobiology and prophylaxis of human herpesvirus infections. Plenum Press, New York, N.Y.
26. Kinchington, P. R., J. Remenick, J. M. Ostrove, S. E. Straus, W. T. Ruyechan, and J. Hay. 1986. Putative glycoprotein gene of varicella-zoster virus with variable copy numbers of a 42-base-pair repeat sequence has homology to herpes simplex virus glycoprotein C. J. Virol. 59:660-668.
27. Kinchington, P. R., J.-P. Vergnes, P. Defechereux, J. Piette, and S. E. Turse, 1994. Transcriptional mapping of the varicella-zoster virus regulatory genes encoding open reading frames 4 and 63. J. Virol. 68:3570-3581.
28. Koropchak, C. M., P. S. Diaz, and A. M. Arvin. 1989. Investigation of varicella-zoster virus infection of lymphocytes by in situ hybridization. J. Virol. 63:2392-2395.
29. Koropchak, C. M., G. Graham, J. Palmer, M. Winsberg, S. F. Ting, M. Wallace, C. G. Prober, and A. M. Arvin. 1991. Investigation of varicella-zoster virus infection by polymerase chain reaction in the immunocompetent host with acute varicella. J. Infect. Dis. 163:1016-1022.
30. Krause, P. R., and D. M. Klinman. 1995. Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine. J. Pediatr. 127:518-525.
31. LaRussa, P., O. Lungu, I. Hardy, A. Gershon, S. P. Steinberg, and S. Silverstein. 1992. Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J. Virol. 66:1016-1020.
32. Ling, P., P. R. Kinchington, W. T. Ruychan, and J. Hay. 1991. A detailed analysis of transcripts mapping to varicella zoster virus gene 14 (glycoprotein V). Virology 184:625-635.
33. Mahalingam, R., M. Wellish, W. Wolf, A. N. Dueland, R. Cohrs, A. Vafai, and D. Gilden. 1990. Latent VZV DNA in human trigeminal and thoracic ganglia. N. Engl. J. Med. 323:627-631.
34. Mettenleiter, T. C., L. Zsak, F. Zuckermann, N. Sugg, H. Kern, and T. Ben-Porat. 1990. Interaction of glycoprotein gIII with a cellular heparinlike substance mediates adsorption of pseudorabies virus. J. Virol. 64:278-286.
35. Mocarski, E. S., M. Bonyhadi, S. Salimi, J. M. McCune, and H. Kaneshima. 1993. Human cytomegalovirus in a SCID-hu mouse: thymic epithelial cells are prominent targets of viral replication. Proc. Natl. Acad. Sci. USA 90: 104-108.
36. + T lymphocytes and epidermal cells in SCID-hu mice. J. Virol. 69:5236-5242.
37. Ozaki, T., T. Ichikawa, Y. Matsui, H. Kondo, T. Nagai, Y. Asano, K. Yamanishi, and M. Takahashi. 1986. Lymphocyte-associated viremia in varicella. J. Med. Virol. 19:249-253.
38. Plotkin, S. A., S. E. Starr, H. M. Friedman, E. Gonczol, and R. E. Weibel. 1989. Protective effects of Towne cytomegalovirus vaccine against low-passage cytomegalovirus administered as a challenge. J. Infect. Dis. 159:860-865.
39. Robbins, A. K., M. E. Whealy, R. J. Watson, and L. W. Enquist. 1986. Pseudorabies virus gene encoding glycoprotein gIII is not essential for growth in tissue culture. J. Virol. 59:635-645.
40. Sawyer, M. H., Y. N. Wu, C. J. Chamberlin, C. Burgos, S. K. Brodine, W. A. Bowler, A. LaRocco, E. C. Oldfield III, and M. R. Wallace. 1992. Detection of varicella-zoster virus DNA in the oropharynx and blood of patients with varicella. J. Infect. Dis. 166:886-888.
41. Sears, A. E., B. S. McGwire, and B. Roizman. 1991. Infection of polarized MDCK cells with herpes simplex virus 1: two asymmetrically distributed cell receptors interact with different viral proteins. Proc. Natl. Acad. Sci. USA 88:5087-5091.
42. Straus, S., H. S. Aulakh, W. T. Ruychan, J. Hay, T. A. Casey, G. F. Vande Woude, J. Owens, and H. A. Smith. 1981. Structure of varicella-zoster virus DNA. J. Virol. 40:516-525.
43. Takahashi, M., T. Otsuka, Y. Okuno, Y. Asano, T. Yazaki, and S. Isomura. 1974. Live vaccine used to prevent the spread of varicalla in children in hospital. Lancet ii:1288-1290.
44. von Bokay, J. 1892. Das Auftreten der Schafblattern uter besonderen Umstanden. Ungerer's Arch. Med. 1:159.
45. Whitley, R. J. 1990. In G. Galasso, R. Whitley, and T. C. Merigan (ed.), Antiviral agents and viral diseases of man, p. 235-264. Raven Press, New York, N.Y.
46. Wilson, A., M. Sharp, C. M. Koropchak, S. F. Ting, and A. M. Arvin. 1991 Subclinical varicella-zoster virus viremia, herpes zoster and recovery of T-lymphocyte responses to varicella-zoster viral antigens after allogeneic and autologous bone marrow transplantation. J. Infect. Dis. 165:119-126.
47. Zhu, Z., M. D. Gershon, R. Ambron, C. Gabel, and A. A. Gershon. 1995. Infection of cells by varicella zoster virus: inhibition of viral entry by mannose 6-phosphate and heparin. Proc. Natl. Acad. Sci. USA 92:3546-3550.